JMI Syringes & Medical Devices Limited announcements
208 Dhaka Stock Exchange announcements for JMI Syringes & Medical Devices Limited (JMISMDL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2013 (16).
- Sponsors Share Buy
Mr. Md. Kaisar Ahmed, one of the Directors (Public Shareholder Director) of the Company, has expressed his intention to buy 96,500 shares of the Company at prevailing market price through Stock Exchange within October 31, 2013.
- (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2013 (July'13 to Sep'13), the Com
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2013 (July'13 to Sep'13), the Company has reported net profit after tax of Tk. 5.49 million with EPS of Tk. 0.50 as against Tk. 4.79 million and Tk. 0.44 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 16.27 million with EPS of Tk. 1.48 for the period of nine months (Jan'13 to Sep'13) ended on 30.09.2013 as against Tk. 11.98 million and Tk. 1.09 respectively for the same period of the previous year.
- Credit Rating
Alpha Credit Rating Limited (AlphaRating) has rated the Company as "A-" in the long term and "AR-2" in the short term along with a stable outlook based on audited financial information of the Company up to 31st December 2012 and relevant qualitative information up to September 30, 2013.
- Alpha Credit Rating Limited (AlphaRating) has rated the Company as "A-" in the long term and "AR-2" in the short term al
Alpha Credit Rating Limited (AlphaRating) has rated the Company as "A-" in the long term and "AR-2" in the short term along with a stable outlook based on audited financial information of the Company up to 31st December 2012 and relevant qualitative information up to September 30, 2013.
- No Price Sensitive Information
The Company has sent the following message to the investors in the capital market: "We don't have any price sensitive information at this moment and the Board of Directors of JMI Syringes & Medical Devices Ltd. did not take any decision at this moment which may cause unusual price movement of our shares recently. Our honorable investors may not consider any rumors related with our Company and take their investment decision prudently."
- The Company has sent the following message to the investors in the capital market: "We don't have any price sensitive in
The Company has sent the following message to the investors in the capital market: "We don't have any price sensitive information at this moment and the Board of Directors of JMI Syringes & Medical Devices Ltd. did not take any decision at this moment which may cause unusual price movement of our shares recently. Our honorable investors may not consider any rumors related with our Company and take their investment decision prudently."
- In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Com
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.
- The Company has informed that it has disbursed cash dividend for the year ended 31st December 2012 to the shareholders t
The Company has informed that it has disbursed cash dividend for the year ended 31st December 2012 to the shareholders through bank account for demate shareholders and for non-demate shareholder, payment made by account payee cheque as on 4th August, 2013.
- (H/Y): As per un-audited half yearly accounts as on 30.06.2013 (Jan'13 to June'13), the Company has reported net profit
(H/Y): As per un-audited half yearly accounts as on 30.06.2013 (Jan'13 to June'13), the Company has reported net profit after tax of Tk. 10.77 million with EPS of Tk. 0.98 as against Tk. 7.19 million and Tk. 0.65 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 9.85 million with EPS of Tk. 0.90 for the period of 3 months (Apr'13 to June'13) ended on 30.06.2013 as against Tk. 4.90 million and Tk. 0.45 respectively for the same period of the previous year.
- Category Change
(Repeat): Trading of the shares of JMI Syringes & Medical Devices Ltd. will commence today (June 19, 2013) at DSE under 'A' category instead of 'N' category as the Company has already traded at CSE under 'A' category. DSE Trading Code for JMI Syringes & Medical Devices Ltd. is "JMISMDL" and DSE Company Code # 18487.
- Open Adjusted Price
(Repeat): This is for information of all concerned that the "Open Adjusted Price" / "Yesterday Close Price" of JMI Syringes & Medical Devices Ltd. is Tk. 32.30 based on the close price of the shares of the Company traded at CSE on 18.06.2013. Regular circuit breaker and circuit filter (price limit) on trading of shares of JMI Syringes & Medical Devices Ltd. shall be imposed from the first trading day (i.e. 19.06.2013) at DSE.
- (Repeat): (Audited Financial Statements): As per audited financial statements for the year ended on 31 December 2012 (Ja
(Repeat): (Audited Financial Statements): As per audited financial statements for the year ended on 31 December 2012 (Jan'12 to Dec'12), the Company has reported net profit after tax of Tk. 12.34 million with EPS of Tk. 1.12 as against Tk. 11.57 million and Tk. 1.05 respectively for the previous year. It is to be noted that EPS has been calculated based on weighted average number of shares of the Company. The Board of Directors of the Company in its 104th Board Meeting held on 28.04.2013 recommended cash dividend @ 12% (i.e. Tk. 1.20 per share of Tk. 10.00 each) on the profit of the Company for the year ended on 31.12. 2012. Date of AGM: 06.07.2013, Time: 10:30 AM, Venue: White House Hotel, 155, Shantinagar, Dhaka-1217. Record Date: 16.05.2013.
- (Q1): (Repeat): As per un-audited quarterly accounts for the 1st quarter ended on 31 March 2013 (January to March 2013),
(Q1): (Repeat): As per un-audited quarterly accounts for the 1st quarter ended on 31 March 2013 (January to March 2013), the Company has reported profit after tax Tk. 0.92 million with EPS Tk. 0.08 as against profit after tax Tk. 2.28 million and EPS Tk. 0.21 respectively for the same period of the previous year. It is to be noted that the said EPS has been calculated based on weighted average paid-up number of shares i.e. 11,000,000 shares for both 2013 & 2012.
- (Repeat): Trading of the shares of JMI Syringes & Medical Devices Ltd. will commence today (June 19, 2013) at DSE under
(Repeat): Trading of the shares of JMI Syringes & Medical Devices Ltd. will commence today (June 19, 2013) at DSE under 'A' category instead of 'N' category as the Company has already traded at CSE under 'A' category. DSE Trading Code for JMI Syringes & Medical Devices Ltd. is "JMISMDL" and DSE Company Code # 18487.
- (Repeat): This is for information of all concerned that the "Open Adjusted Price" / "Yesterday Close Price" of JMI Syrin
(Repeat): This is for information of all concerned that the "Open Adjusted Price" / "Yesterday Close Price" of JMI Syringes & Medical Devices Ltd. is Tk. 32.30 based on the close price of the shares of the Company traded at CSE on 18.06.2013. Regular circuit breaker and circuit filter (price limit) on trading of shares of JMI Syringes & Medical Devices Ltd. shall be imposed from the first trading day (i.e. 19.06.2013) at DSE.
- Category Change
JMI Syringes & Medical Devices Ltd.: Trading of the shares of JMI Syringes & Medical Devices Ltd. will commence at DSE from June 19, 2013 under 'A' category instead of 'N' category as the Company has already traded at CSE under 'A' category. DSE Trading Code for JMI Syringes & Medical Devices Ltd. is "JMISMDL" and DSE Company Code # 18487.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.